Wei Huang

机构：Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, Henan Academy of Sciences, University of Cincinnati Medical Center · ORCID：0000-0002-8714-4757

发表论文 49 篇 · 总被引 1811 次 · h-index 24

代表论文

• Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer (2021 · Frontiers in Cell and Developmental Biology · 被引 117)
• RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis (2022 · Cell Death and Differentiation · 被引 75)
• Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition (2021 · Cell Death and Differentiation · 被引 64)
• SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis (2021 · Cell Death and Differentiation · 被引 52)
• High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial (2024 · The Lancet Respiratory Medicine · 被引 43)
• CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A (2024 · Protein & Cell · 被引 28)